AngioDynamics, Inc. Goodwill, Foreign Currency Translation Gain (Loss)
AngioDynamics, Inc. (ANGO) reported Goodwill, Foreign Currency Translation Gain (Loss) of $238.00 thousand for the 12-month period ending 2024-05-31, per its 10-K filed 2024-07-25.
Discontinued › Income Statement › Other Income
us-gaap:GoodwillForeignCurrencyTranslationGainLoss · last filed 2024-07-25
- AngioDynamics, Inc. goodwill, foreign currency translation gain (loss) for the quarter ending 2024-05-31 was $0.00.
- AngioDynamics, Inc. goodwill, foreign currency translation gain (loss) for the quarter ending 2024-02-29 was $250.00K.
- AngioDynamics, Inc. goodwill, foreign currency translation gain (loss) for the quarter ending 2023-11-30 was $209.00K.
- AngioDynamics, Inc. goodwill, foreign currency translation gain (loss) for the quarter ending 2023-08-31 was -$221.00K.
- AngioDynamics, Inc. goodwill, foreign currency translation gain (loss) for fiscal 2024 was $238.00K.
- AngioDynamics, Inc. goodwill, foreign currency translation gain (loss) for fiscal 2023 was -$1.29M.
| Period end | Goodwill, Foreign Currency Translation Gain (Loss) 3 month | Goodwill, Foreign Currency Translation Gain (Loss) 6 month | Goodwill, Foreign Currency Translation Gain (Loss) 9 month | Goodwill, Foreign Currency Translation Gain (Loss) 12 month |
|---|---|---|---|---|
| 2024-05-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2024-07-25 | $250.00K derived: sum of 2 quarters · filed 2024-07-25 | $459.00K derived: sum of 3 quarters · filed 2024-07-25 | $238.00K 10-K · filed 2024-07-25 |
| 2024-02-29 | $250.00K 10-Q · filed 2024-04-09 | $459.00K derived: sum of 2 quarters · filed 2024-04-09 | $238.00K derived: sum of 3 quarters · filed 2024-04-09 | |
| 2023-11-30 | $209.00K 10-Q · filed 2024-04-09 | -$12.00K derived: sum of 2 quarters · filed 2024-04-09 | ||
| 2023-08-31 | -$221.00K 10-Q · filed 2024-04-09 | |||
| 2023-05-31 | -$1.29M 10-K · filed 2024-07-25 | |||
| 2023-02-28 | -$779.00K 10-Q · filed 2023-03-31 | -$1.06M derived: sum of 2 quarters · filed 2023-03-31 | -$1.08M derived: sum of 3 quarters · filed 2023-03-31 | |
| 2022-11-30 | -$283.00K 10-Q · filed 2023-03-31 | -$303.00K derived: sum of 2 quarters · filed 2023-03-31 | ||
| 2022-08-31 | -$20.00K 10-Q · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |